• Founded: 2020
  • Location: Los Angeles, CA
  • Employee range: 1-50
  • Funding: 100-500M

job board

Short description:

Contact us to add description:

Drug notes:

Contact us to add description:

Long description:

ACELYRIN is investing in, developing and commercializing life-changing drug therapies. ACELYRIN’s approach is to identify and develop therapeutics through efficient and ongoing collaborations with academia, big-pharma and early-stage start-ups to get the right expertise throughout the entire process. ACELYRIN’s lead candidate is izokibep, a monoclonal antibody mimetic to inhibit interleukin-17A (IL-17A) with high potency and tissue penetrance. Currently, ACELYRIN is actively investigating the potential of izokibep in diseases with perturbed IL-17A signaling. This includes Phase 2/3 trials for inflammatory diseases of the eye (Uveitis) and skin (Psoriatic Arthritis).


© 2024 Work In Biotech LLC
Personal data

Terms of Service

Privacy Policy